Brief: Genmab Is Said To Near Deal To Buy Cancer Drugmaker Merus - Bloomberg News
Sept 28 (Reuters) - GENMAB IS SAID TO NEAR DEAL TO BUY CANCER DRUGMAKER MERUS - BLOOMBERG NEWS Source text: https://tinyurl.com/mrnyu447 Further company coverage: 2GH.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merus NV
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Merus And Halozyme enter global collaboration and license agreement to develop subcutaneous formulation Of Petosemtamab